| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | zinc ion binding | MYT1L TRIM49 ZNF346 TUT4 ZEB1 POLA1 TRIM49C ZSWIM2 MARCHF7 MDM2 TRIP12 SUV39H2 SCAPER NFXL1 ADAMTS20 CZIB MME ARHGEF2 NUP153 AGTPBP1 USP33 | 1.50e-05 | 891 | 165 | 21 | GO:0008270 |
| GeneOntologyMolecularFunction | transition metal ion binding | MYT1L ADCY10 TRIM49 ZNF346 TUT4 ZEB1 POLA1 CYP17A1 TRIM49C ZSWIM2 MARCHF7 MDM2 TRIP12 SUV39H2 SCAPER NFXL1 ADAMTS20 CZIB MME LTF ARHGEF2 NUP153 AGTPBP1 USP33 | 4.45e-05 | 1189 | 165 | 24 | GO:0046914 |
| GeneOntologyMolecularFunction | NAD+-protein poly-ADP-ribosyltransferase activity | 7.88e-05 | 28 | 165 | 4 | GO:0003950 | |
| GeneOntologyMolecularFunction | NAD+-protein ADP-ribosyltransferase activity | 1.04e-04 | 30 | 165 | 4 | GO:1990404 | |
| GeneOntologyMolecularFunction | ADP-D-ribose binding | 2.03e-04 | 3 | 165 | 2 | GO:0072570 | |
| GeneOntologyMolecularFunction | enzyme regulator activity | ROCK2 ARHGEF28 PSAP MYO9A DOCK9 PARP8 NAIP ARFGEF1 SPOCK2 MACROH2A1 GRM7 NLRP2 ZEB2 DENND3 TIAM2 RAD50 PARP6 TGFBR2 VAC14 NF1 KNDC1 PARP9 LTF ARHGEF2 AGAP2 | 2.59e-04 | 1418 | 165 | 25 | GO:0030234 |
| GeneOntologyMolecularFunction | kinase activator activity | 3.61e-04 | 159 | 165 | 7 | GO:0019209 | |
| GeneOntologyMolecularFunction | cytoskeleton-nuclear membrane anchor activity | 6.68e-04 | 5 | 165 | 2 | GO:0140444 | |
| GeneOntologyBiologicalProcess | intracellular transport | PSAP AFTPH TRAF3IP1 MYO5B ABCA12 SYNE1 NCBP1 GRN SPG11 MDM2 SLC30A4 DCTN1 WDPCP DENND3 NPLOC4 DST NF1 STXBP3 GLP1R SYNE2 TTC21B DYNC1LI1 LRRC7 TACC1 ARHGEF2 NUP153 AGTPBP1 RHOT1 HTT AGAP2 SMG6 | 6.41e-07 | 1496 | 163 | 31 | GO:0046907 |
| GeneOntologyBiologicalProcess | microtubule-based transport | ADCY10 TRAF3IP1 SPG11 DCTN1 WDPCP CFAP54 DST SYNE2 TTC21B AGTPBP1 RHOT1 HTT | 8.44e-07 | 253 | 163 | 12 | GO:0099111 |
| GeneOntologyBiologicalProcess | microtubule-based process | ROCK2 ADCY10 MCPH1 TRAF3IP1 SDCCAG8 CNTRL SPG11 PRC1 MAP10 DCTN1 WDPCP CFAP54 DST BRCA2 SYNE2 NAT10 TTC21B DYNC1LI1 CFAP74 TACC1 ARHGEF2 AGTPBP1 RHOT1 USP33 HTT | 8.97e-07 | 1058 | 163 | 25 | GO:0007017 |
| GeneOntologyBiologicalProcess | cytoskeleton-dependent intracellular transport | TRAF3IP1 MYO5B SPG11 DCTN1 WDPCP DST SYNE2 TTC21B AGTPBP1 RHOT1 HTT | 1.83e-06 | 225 | 163 | 11 | GO:0030705 |
| GeneOntologyBiologicalProcess | transport along microtubule | TRAF3IP1 SPG11 DCTN1 WDPCP DST SYNE2 TTC21B AGTPBP1 RHOT1 HTT | 3.90e-06 | 197 | 163 | 10 | GO:0010970 |
| GeneOntologyBiologicalProcess | establishment or maintenance of cell polarity | ROCK2 MCPH1 MYO9A SDCCAG8 ARFGEF1 DCTN1 WDPCP DST LRRC7 ARHGEF2 HTT | 6.56e-06 | 257 | 163 | 11 | GO:0007163 |
| GeneOntologyBiologicalProcess | establishment of cell polarity | 1.19e-05 | 177 | 163 | 9 | GO:0030010 | |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | ROCK2 MCPH1 TRAF3IP1 SDCCAG8 CNTRL PRC1 MAP10 DCTN1 DST BRCA2 SYNE2 NAT10 DYNC1LI1 CFAP74 TACC1 ARHGEF2 USP33 HTT | 1.65e-05 | 720 | 163 | 18 | GO:0000226 |
| GeneOntologyBiologicalProcess | regulation of microtubule-based process | ROCK2 MCPH1 TRAF3IP1 MAP10 DCTN1 NAT10 TTC21B DYNC1LI1 TACC1 ARHGEF2 RHOT1 | 2.23e-05 | 293 | 163 | 11 | GO:0032886 |
| GeneOntologyBiologicalProcess | centrosome cycle | 4.92e-05 | 164 | 163 | 8 | GO:0007098 | |
| GeneOntologyBiologicalProcess | regulation of cell projection organization | ADCY10 MYO5B MYO9A SYNE1 SDCCAG8 MARCHF7 GRN MDM2 ZEB2 WDPCP TIAM2 PARP6 NF1 SYNE2 KNDC1 LRRC7 CDH4 GOLGA4 HTT | 5.39e-05 | 863 | 163 | 19 | GO:0031344 |
| GeneOntologyBiologicalProcess | neuron development | MYT1L ROCK2 ADCY10 ARHGEF28 MYO5B MYO9A SYNE1 ARFGEF1 GRN SPG11 MDM2 GRM7 ZEB2 WDPCP TIAM2 LHX9 PARP6 DST NF1 KNDC1 LRRC7 CDH4 GOLGA4 AGTPBP1 USP33 HTT | 8.20e-05 | 1463 | 163 | 26 | GO:0048666 |
| GeneOntologyBiologicalProcess | ossification involved in bone maturation | 8.78e-05 | 30 | 163 | 4 | GO:0043931 | |
| GeneOntologyBiologicalProcess | microtubule organizing center organization | 9.11e-05 | 179 | 163 | 8 | GO:0031023 | |
| GeneOntologyBiologicalProcess | cell differentiation in hindbrain | 1.14e-04 | 32 | 163 | 4 | GO:0021533 | |
| GeneOntologyBiologicalProcess | bone maturation | 1.29e-04 | 33 | 163 | 4 | GO:0070977 | |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection organization | ADCY10 MYO5B SYNE1 SDCCAG8 MARCHF7 GRN MDM2 ZEB2 WDPCP TIAM2 PARP6 NF1 SYNE2 KNDC1 LRRC7 CDH4 GOLGA4 HTT | 1.32e-04 | 846 | 163 | 18 | GO:0120035 |
| GeneOntologyBiologicalProcess | nuclear migration | 1.45e-04 | 34 | 163 | 4 | GO:0007097 | |
| GeneOntologyBiologicalProcess | cerebellar cortex formation | 1.45e-04 | 34 | 163 | 4 | GO:0021697 | |
| GeneOntologyBiologicalProcess | microtubule-based movement | ADCY10 TRAF3IP1 SPG11 DCTN1 WDPCP CFAP54 DST SYNE2 TTC21B DYNC1LI1 AGTPBP1 RHOT1 HTT | 1.54e-04 | 493 | 163 | 13 | GO:0007018 |
| GeneOntologyBiologicalProcess | animal organ maturation | 2.03e-04 | 37 | 163 | 4 | GO:0048799 | |
| GeneOntologyBiologicalProcess | regulation of cilium assembly | 2.19e-04 | 108 | 163 | 6 | GO:1902017 | |
| GeneOntologyBiologicalProcess | cilium assembly | TRAF3IP1 SYNE1 SDCCAG8 CNTRL MARCHF7 DCTN1 WDPCP CFAP54 SYNE2 TTC21B CFAP74 HTT | 2.21e-04 | 444 | 163 | 12 | GO:0060271 |
| GeneOntologyBiologicalProcess | establishment of mitotic spindle orientation | 2.49e-04 | 39 | 163 | 4 | GO:0000132 | |
| GeneOntologyBiologicalProcess | positive regulation of axonogenesis | 2.93e-04 | 114 | 163 | 6 | GO:0050772 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | ROCK2 ADCY10 ARHGEF28 MYO5B SYNE1 SPG11 ZEB2 WDPCP TIAM2 LHX9 PARP6 DST KNDC1 CDH4 GOLGA4 USP33 | 2.98e-04 | 748 | 163 | 16 | GO:0048667 |
| GeneOntologyBiologicalProcess | cerebellar Purkinje cell differentiation | 3.62e-04 | 18 | 163 | 3 | GO:0021702 | |
| GeneOntologyBiologicalProcess | corneocyte development | 3.69e-04 | 4 | 163 | 2 | GO:0003335 | |
| GeneOntologyBiologicalProcess | response to psychosocial stress | 3.69e-04 | 4 | 163 | 2 | GO:1990911 | |
| GeneOntologyBiologicalProcess | nucleus localization | 3.99e-04 | 44 | 163 | 4 | GO:0051647 | |
| GeneOntologyBiologicalProcess | establishment of mitotic spindle localization | 3.99e-04 | 44 | 163 | 4 | GO:0040001 | |
| GeneOntologyBiologicalProcess | cilium organization | TRAF3IP1 SYNE1 SDCCAG8 CNTRL MARCHF7 DCTN1 WDPCP CFAP54 SYNE2 TTC21B CFAP74 HTT | 4.15e-04 | 476 | 163 | 12 | GO:0044782 |
| HumanPheno | Vocal cord dysfunction | 2.85e-05 | 57 | 55 | 6 | HP:0031801 | |
| HumanPheno | Vocal cord paralysis | 2.85e-05 | 57 | 55 | 6 | HP:0001605 | |
| HumanPheno | Vocal cord paresis | 2.85e-05 | 57 | 55 | 6 | HP:0001604 | |
| HumanPheno | Weakness of the vocal cords | 2.85e-05 | 57 | 55 | 6 | HP:0001603 | |
| HumanPheno | Abnormal vocal cord morphology | 4.22e-05 | 61 | 55 | 6 | HP:0008777 | |
| HumanPheno | Proximal lower limb amyotrophy | 5.19e-05 | 20 | 55 | 4 | HP:0008956 | |
| HumanPheno | Abnormal systemic blood pressure | PSAP TRAF3IP1 CYP17A1 SDCCAG8 ELP1 SPG11 MDM2 DCTN1 WDPCP RYR1 TGFBR2 VAC14 DST NF1 BRCA2 SCAPER CORIN | 5.99e-05 | 569 | 55 | 17 | HP:0030972 |
| HumanPheno | Abnormality thigh musculature morphology | 6.35e-05 | 21 | 55 | 4 | HP:0001441 | |
| Domain | Poly(ADP-ribose)pol_cat_dom | 1.19e-05 | 17 | 162 | 4 | IPR012317 | |
| Domain | PARP_CATALYTIC | 1.19e-05 | 17 | 162 | 4 | PS51059 | |
| Domain | PARP | 1.19e-05 | 17 | 162 | 4 | PF00644 | |
| Domain | - | 1.19e-05 | 17 | 162 | 4 | 3.90.228.10 | |
| Domain | ARM-type_fold | DOCK9 ARFGEF1 NCBP1 BTAF1 TRRAP TRIP12 VAC14 NF1 UTP20 UNC79 AGTPBP1 HTT | 4.15e-05 | 339 | 162 | 12 | IPR016024 |
| Domain | NACHT | 4.25e-05 | 23 | 162 | 4 | PS50837 | |
| Domain | NACHT_NTPase | 4.25e-05 | 23 | 162 | 4 | IPR007111 | |
| Domain | WGR_domain | 5.06e-05 | 24 | 162 | 4 | IPR008893 | |
| Domain | Matrilin-3/4 | 7.48e-05 | 2 | 162 | 2 | IPR030765 | |
| Domain | - | 1.41e-04 | 222 | 162 | 9 | 1.25.10.10 | |
| Domain | P-loop_NTPase | ADCY10 MYO5B MYO9A ABCA12 NAIP RNF213 DAPK1 BTAF1 SLFN5 GIMAP7 NLRP2 SBNO2 RAD50 NLRP9 ATAD2B RAD54B DYNC1LI1 RHOT1 AGAP2 | 1.44e-04 | 848 | 162 | 19 | IPR027417 |
| Domain | ZF_DAG_PE_1 | 2.33e-04 | 64 | 162 | 5 | PS00479 | |
| Domain | ZF_DAG_PE_2 | 2.33e-04 | 64 | 162 | 5 | PS50081 | |
| Domain | C1 | 2.51e-04 | 65 | 162 | 5 | SM00109 | |
| Domain | PE/DAG-bd | 2.69e-04 | 66 | 162 | 5 | IPR002219 | |
| Domain | KASH | 4.44e-04 | 4 | 162 | 2 | IPR012315 | |
| Domain | KASH | 4.44e-04 | 4 | 162 | 2 | PS51049 | |
| Domain | Matrilin_ccoil | 4.44e-04 | 4 | 162 | 2 | SM01279 | |
| Domain | KASH | 4.44e-04 | 4 | 162 | 2 | SM01249 | |
| Domain | - | 4.44e-04 | 4 | 162 | 2 | 1.20.5.30 | |
| Domain | KASH | 4.44e-04 | 4 | 162 | 2 | PF10541 | |
| Domain | Matrilin_ccoil | 4.44e-04 | 4 | 162 | 2 | PF10393 | |
| Domain | Matrilin_coiled-coil_trimer | 4.44e-04 | 4 | 162 | 2 | IPR019466 | |
| Domain | ARM-like | 5.96e-04 | 270 | 162 | 9 | IPR011989 | |
| Domain | - | ADCY10 ABCA12 NAIP RNF213 BTAF1 SLFN5 GIMAP7 NLRP2 SBNO2 RAD50 NLRP9 ATAD2B RAD54B DYNC1LI1 RHOT1 AGAP2 | 7.87e-04 | 746 | 162 | 16 | 3.40.50.300 |
| Domain | HEAT | 7.88e-04 | 48 | 162 | 4 | PF02985 | |
| Domain | DAPIN | 8.74e-04 | 22 | 162 | 3 | PS50824 | |
| Domain | PYRIN | 8.74e-04 | 22 | 162 | 3 | SM01289 | |
| Domain | PYRIN | 8.74e-04 | 22 | 162 | 3 | PF02758 | |
| Domain | DAPIN | 8.74e-04 | 22 | 162 | 3 | IPR004020 | |
| Domain | Spectrin | 9.99e-04 | 23 | 162 | 3 | PF00435 | |
| Domain | ZF_RANBP2_2 | 9.99e-04 | 23 | 162 | 3 | PS50199 | |
| Domain | ACTININ_2 | 9.99e-04 | 23 | 162 | 3 | PS00020 | |
| Domain | ACTININ_1 | 9.99e-04 | 23 | 162 | 3 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 9.99e-04 | 23 | 162 | 3 | IPR001589 | |
| Domain | ZF_RANBP2_1 | 1.13e-03 | 24 | 162 | 3 | PS01358 | |
| Domain | Znf_RanBP2 | 1.28e-03 | 25 | 162 | 3 | IPR001876 | |
| Domain | LRR_6 | 1.32e-03 | 55 | 162 | 4 | PF13516 | |
| Domain | C1_1 | 1.51e-03 | 57 | 162 | 4 | PF00130 | |
| Domain | DUF3456 | 1.53e-03 | 7 | 162 | 2 | PF11938 | |
| Domain | zf-Di19 | 1.53e-03 | 7 | 162 | 2 | PF05605 | |
| Domain | Di19_Zn_binding_dom | 1.53e-03 | 7 | 162 | 2 | IPR008598 | |
| Domain | DUF3456 | 1.53e-03 | 7 | 162 | 2 | IPR021852 | |
| Domain | HEAT | 1.61e-03 | 58 | 162 | 4 | IPR000357 | |
| Domain | Spectrin_repeat | 1.98e-03 | 29 | 162 | 3 | IPR002017 | |
| Domain | - | 2.23e-03 | 207 | 162 | 7 | 1.25.40.10 | |
| Domain | CH | 2.45e-03 | 65 | 162 | 4 | SM00033 | |
| Domain | A1pp | 2.59e-03 | 9 | 162 | 2 | SM00506 | |
| Domain | Macro | 2.59e-03 | 9 | 162 | 2 | PF01661 | |
| Domain | SAP_B | 2.59e-03 | 9 | 162 | 2 | PS50015 | |
| Domain | SPEC | 2.64e-03 | 32 | 162 | 3 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 2.64e-03 | 32 | 162 | 3 | IPR018159 | |
| Domain | CH | 3.21e-03 | 70 | 162 | 4 | PF00307 | |
| Domain | HEAT_REPEAT | 3.21e-03 | 70 | 162 | 4 | PS50077 | |
| Domain | Macro_dom | 3.21e-03 | 10 | 162 | 2 | IPR002589 | |
| Domain | MACRO | 3.21e-03 | 10 | 162 | 2 | PS51154 | |
| Domain | - | 3.37e-03 | 71 | 162 | 4 | 1.10.418.10 | |
| Domain | CH | 3.73e-03 | 73 | 162 | 4 | PS50021 | |
| Domain | CH-domain | 4.11e-03 | 75 | 162 | 4 | IPR001715 | |
| Domain | TPR-like_helical_dom | 4.28e-03 | 233 | 162 | 7 | IPR011990 | |
| Domain | TGFB_receptor | 4.66e-03 | 12 | 162 | 2 | IPR000333 | |
| Domain | MIRO-like | 5.48e-03 | 13 | 162 | 2 | IPR013684 | |
| Domain | Roc | 5.48e-03 | 13 | 162 | 2 | PF08477 | |
| Domain | VWFA | 5.65e-03 | 82 | 162 | 4 | PS50234 | |
| Domain | VWA | 6.15e-03 | 84 | 162 | 4 | SM00327 | |
| Domain | TUDOR | 6.35e-03 | 14 | 162 | 2 | PF00567 | |
| Domain | EGF_CA | 6.67e-03 | 86 | 162 | 4 | PF07645 | |
| Domain | - | 7.04e-03 | 321 | 162 | 8 | 3.80.10.10 | |
| Domain | L_dom-like | 7.96e-03 | 328 | 162 | 8 | IPR032675 | |
| Pathway | REACTOME_MATURATION_OF_SARS_COV_1_NUCLEOPROTEIN | 1.68e-06 | 11 | 122 | 4 | M39011 | |
| Pathway | REACTOME_MATURATION_OF_SARS_COV_2_NUCLEOPROTEIN | 6.77e-06 | 15 | 122 | 4 | M44001 | |
| Pathway | REACTOME_NICOTINAMIDE_SALVAGING | 1.87e-05 | 19 | 122 | 4 | M27094 | |
| Pathway | REACTOME_NICOTINAMIDE_SALVAGING | 1.87e-05 | 19 | 122 | 4 | MM14774 | |
| Pathway | REACTOME_TRANSLATION_OF_SARS_COV_1_STRUCTURAL_PROTEINS | 1.07e-04 | 29 | 122 | 4 | M39014 | |
| Pathway | WP_DNA_IRDOUBLE_STRAND_BREAKS_AND_CELLULAR_RESPONSE_VIA_ATM | 1.10e-04 | 55 | 122 | 5 | M39598 | |
| Pathway | WP_HOMOLOGOUS_RECOMBINATION | 1.31e-04 | 12 | 122 | 3 | MM15951 | |
| Pathway | REACTOME_NICOTINATE_METABOLISM | 1.40e-04 | 31 | 122 | 4 | M27089 | |
| Pathway | REACTOME_NICOTINATE_METABOLISM | 1.40e-04 | 31 | 122 | 4 | MM14767 | |
| Pathway | WP_HOMOLOGOUS_RECOMBINATION | 1.70e-04 | 13 | 122 | 3 | M39712 | |
| Pathway | REACTOME_LATE_SARS_COV_2_INFECTION_EVENTS | 3.45e-04 | 70 | 122 | 5 | M46438 | |
| Pubmed | ROCK2 ZEB1 LRCH2 TRAF3IP1 SYNE1 DAPK1 MACROH2A1 DCTN1 ZEB2 RAD50 DST NF1 SYNE2 NAT10 ZBTB21 LRRC7 ARHGEF2 UNC79 GOLGA4 NUP153 AGAP2 SMG6 | 1.41e-09 | 963 | 166 | 22 | 28671696 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | ROCK2 ZEB1 AFTPH BACH1 BTAF1 TRRAP TRIP12 ZFX RAD50 NF1 ZBTB21 DYNC1LI1 UTP20 ARHGEF2 HSF1 GOLGA4 NUP153 AGTPBP1 | 3.76e-08 | 774 | 166 | 18 | 15302935 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | TUT4 MCPH1 CMC1 MYO9A INPP4A SDCCAG8 NAIP RNF213 MACROH2A1 BTAF1 SLC30A4 TRRAP NPLOC4 SBNO2 ZNF461 PPP4C TESMIN NAT10 TTC21B KNDC1 LRRC7 MME GOLGA4 HTT SMG6 | 4.64e-08 | 1489 | 166 | 25 | 28611215 |
| Pubmed | 5.11e-08 | 151 | 166 | 9 | 17043677 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | CPNE8 MYO5B SYNE1 ELP1 NCBP1 GRN MACROH2A1 BTAF1 TRRAP TRIP12 RAD50 DST NF1 SLC12A2 SYNE2 NAT10 ZBTB21 UTP20 ARHGEF2 NUP153 | 1.09e-07 | 1024 | 166 | 20 | 24711643 |
| Pubmed | ROCK2 MYO5B SYNE1 PARP8 CNTRL ZSCAN26 NCBP1 SPG11 MACROH2A1 DCTN1 TRIP12 ZEB2 ADAMTS12 DST TESMIN CIAO3 DGKK SYNE2 ZBTB21 NFXL1 CFAP74 ARHGEF2 AGAP2 | 4.17e-07 | 1442 | 166 | 23 | 35575683 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | MCPH1 POLA1 RNF213 NCBP1 GRN AMER3 SLFN5 GIMAP7 TRIP12 RYR1 PARP4 DST AGL ATAD2B UTP20 LRRC7 | 5.48e-07 | 736 | 166 | 16 | 29676528 |
| Pubmed | ARHGEF28 ELP1 BTAF1 FHIP2A DENND3 NPLOC4 SBNO2 SMYD4 PARP4 DST RAD54B NFXL1 ARHGEF2 RHOT1 USP33 | 6.00e-07 | 650 | 166 | 15 | 38777146 | |
| Pubmed | POLA1 ELP1 NCBP1 TRRAP TRIP12 RAD50 DST NF1 FANCI ATAD2B SYNE2 NAT10 UTP20 LTF NUP153 | 6.35e-07 | 653 | 166 | 15 | 22586326 | |
| Pubmed | CTDP1 regulates breast cancer survival and DNA repair through BRCT-specific interactions with FANCI. | 7.16e-07 | 104 | 166 | 7 | 31240132 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | ROCK2 ELP1 NCBP1 BTAF1 DCTN1 TRIP12 RAD50 PARP4 NF1 FANCI NAT10 DYNC1LI1 ARHGEF2 NUP153 | 8.89e-07 | 582 | 166 | 14 | 20467437 |
| Pubmed | ZEB1, ZEB2, and the miR-200 family form a counterregulatory network to regulate CD8+ T cell fates. | 1.06e-06 | 5 | 166 | 3 | 29449309 | |
| Pubmed | PSAP SYNE1 DOCK9 ELP1 MDM2 DCTN1 RYR1 PARP4 DST AGL SYNE2 AGTPBP1 | 5.30e-06 | 497 | 166 | 12 | 23414517 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | MYO9A POLA1 ELP1 MACROH2A1 DCTN1 TRRAP TRIP12 ZBED5 RAD50 DST NF1 FANCI NAT10 NFXL1 DYNC1LI1 UTP20 PRR14L LTF ARHGEF2 GOLGA4 | 7.81e-06 | 1353 | 166 | 20 | 29467282 |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | POLA1 ZSCAN26 NCBP1 BTAF1 TRRAP TRIP12 SUV39H2 ZEB2 FANCI ATAD2B NAT10 RAD54B ZBTB21 | 7.89e-06 | 608 | 166 | 13 | 36089195 |
| Pubmed | FBXO32 links ubiquitination to epigenetic reprograming of melanoma cells. | 8.83e-06 | 212 | 166 | 8 | 33462405 | |
| Pubmed | The deubiquitinase TRABID stabilizes the K29/K48-specific E3 ubiquitin ligase HECTD1. | 8.83e-06 | 212 | 166 | 8 | 33853758 | |
| Pubmed | 1.42e-05 | 31 | 166 | 4 | 19690177 | ||
| Pubmed | Multiple roles of FOXJ3 in spermatogenesis: A lesson from Foxj3 conditional knockout mouse models. | 1.62e-05 | 32 | 166 | 4 | 27739607 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | MACROH2A1 BTAF1 PRC1 MDM2 DCTN1 TRRAP TRIP12 ZEB2 RAD50 AGL ZBTB21 NFXL1 UTP20 ARHGEF2 AGTPBP1 | 1.69e-05 | 857 | 166 | 15 | 25609649 |
| Pubmed | 1.71e-05 | 11 | 166 | 3 | 22826121 | ||
| Pubmed | 1.71e-05 | 11 | 166 | 3 | 15001356 | ||
| Pubmed | 1.80e-05 | 234 | 166 | 8 | 36243803 | ||
| Pubmed | ROCK2 NPLOC4 DST SLC12A2 ANO6 SYNE2 NFXL1 TACC1 PRR14L GOLGA4 NUP153 USP33 | 2.00e-05 | 568 | 166 | 12 | 37774976 | |
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 28416756 | ||
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 33173438 | ||
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 24306957 | ||
| Pubmed | Prognostic Significance of Zinc Finger E-Box-Binding Homeobox Family in Glioblastoma. | 2.26e-05 | 2 | 166 | 2 | 29476046 | |
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 11792814 | ||
| Pubmed | Nesprin-1 and nesprin-2 regulate endothelial cell shape and migration. | 2.26e-05 | 2 | 166 | 2 | 24931616 | |
| Pubmed | The mesodermal and myogenic specification of hESCs depend on ZEB1 and are inhibited by ZEB2. | 2.26e-05 | 2 | 166 | 2 | 37819755 | |
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 33907289 | ||
| Pubmed | Tight coordination of protein translation and HSF1 activation supports the anabolic malignant state. | 2.26e-05 | 2 | 166 | 2 | 23869022 | |
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 31864418 | ||
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 32488136 | ||
| Pubmed | Poly-glutamine expanded huntingtin dramatically alters the genome wide binding of HSF1. | 2.26e-05 | 2 | 166 | 2 | 23293686 | |
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 20025777 | ||
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 21747944 | ||
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 36964914 | ||
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 37948583 | ||
| Pubmed | Alpha-fetoprotein and Fanconi Anemia: Relevance to DNA Repair and Breast Cancer Susceptibility. | 2.26e-05 | 2 | 166 | 2 | 27690720 | |
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 37804415 | ||
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 34550965 | ||
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 22768332 | ||
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 34374777 | ||
| Pubmed | ZEBs: Novel Players in Immune Cell Development and Function. | 2.26e-05 | 2 | 166 | 2 | 30956067 | |
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 21785217 | ||
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 12609600 | ||
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 20375168 | ||
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 22213144 | ||
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 30460377 | ||
| Pubmed | Functional conservation of zinc-finger homeodomain gene zfh1/SIP1 in Drosophila heart development. | 2.26e-05 | 2 | 166 | 2 | 16957952 | |
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 28970536 | ||
| Pubmed | Prosaposin is a regulator of progranulin levels and oligomerization. | 2.26e-05 | 2 | 166 | 2 | 27356620 | |
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 37018978 | ||
| Pubmed | Syne-1 and Syne-2 play crucial roles in myonuclear anchorage and motor neuron innervation. | 2.26e-05 | 2 | 166 | 2 | 17267447 | |
| Pubmed | Nesprins: tissue-specific expression of epsilon and other short isoforms. | 2.26e-05 | 2 | 166 | 2 | 24718612 | |
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 24586179 | ||
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 22892238 | ||
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 25082886 | ||
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 21969577 | ||
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 17761684 | ||
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 20424117 | ||
| Pubmed | Activation of 5-HT(2C) receptor promotes the expression of neprilysin in U251 human glioma cells. | 2.26e-05 | 2 | 166 | 2 | 25452160 | |
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 31578382 | ||
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 28133913 | ||
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 28640985 | ||
| Pubmed | BPAG1n4 is essential for retrograde axonal transport in sensory neurons. | 2.26e-05 | 2 | 166 | 2 | 14581450 | |
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 36233357 | ||
| Pubmed | 2.95e-05 | 13 | 166 | 3 | 21177258 | ||
| Pubmed | CPNE8 ARFGEF1 SPG11 VAC14 DST SLC12A2 ANO6 SYNE2 TACC1 GOLGA4 USP33 | 3.33e-05 | 504 | 166 | 11 | 34432599 | |
| Pubmed | 3.74e-05 | 14 | 166 | 3 | 20403135 | ||
| Pubmed | 3.74e-05 | 14 | 166 | 3 | 19874786 | ||
| Pubmed | 3.74e-05 | 14 | 166 | 3 | 12563287 | ||
| Pubmed | FSIP1 MACROH2A1 PKHD1L1 ZEB2 WDPCP DENND3 PARP4 MALRD1 ATAD2B ADAMTS20 LRRC7 CDH4 NUP153 RHOT1 | 3.94e-05 | 814 | 166 | 14 | 23251661 | |
| Pubmed | The p97/VCP segregase is essential for arsenic-induced degradation of PML and PML-RARA. | 4.03e-05 | 262 | 166 | 8 | 36880596 | |
| Pubmed | Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism. | ROCK2 CPNE8 TUT4 ZEB1 ARHGEF28 MYO9A DOCK9 PARP8 MDM2 DCTN1 VAC14 CIAO3 FANCI AGL RHOT1 | 4.05e-05 | 925 | 166 | 15 | 28986522 |
| Pubmed | 4.74e-05 | 347 | 166 | 9 | 17114649 | ||
| Pubmed | Network organization of the huntingtin proteomic interactome in mammalian brain. | ROCK2 CPNE8 MYO5B NAIP DCTN1 TRRAP DST BRCA2 ADAMTS20 LRRC7 ARHGEF2 HTT | 4.75e-05 | 621 | 166 | 12 | 22794259 |
| Pubmed | FBXL13 directs the proteolysis of CEP192 to regulate centrosome homeostasis and cell migration. | 4.86e-05 | 42 | 166 | 4 | 29348145 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | 5.46e-05 | 440 | 166 | 10 | 34244565 | |
| Pubmed | TUT4 RNF213 SPG11 STXBP3 SLC12A2 NFXL1 DYNC1LI1 TACC1 PRR14L ARHGEF2 GOLGA4 AGTPBP1 USP33 | 5.49e-05 | 733 | 166 | 13 | 34672954 | |
| Pubmed | 5.62e-05 | 85 | 166 | 5 | 19028597 | ||
| Pubmed | Family-wide analysis of poly(ADP-ribose) polymerase activity. | 5.71e-05 | 16 | 166 | 3 | 25043379 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | CPNE8 AFTPH LRCH2 SDCCAG8 CNTRL GRN FHIP2A DCTN1 RAD50 STXBP3 BRCA2 DYNC1LI1 CZIB ARHGEF2 | 6.49e-05 | 853 | 166 | 14 | 28718761 |
| Pubmed | 6.77e-05 | 3 | 166 | 2 | 21465263 | ||
| Pubmed | 6.77e-05 | 3 | 166 | 2 | 21890822 | ||
| Pubmed | 6.77e-05 | 3 | 166 | 2 | 29726012 | ||
| Pubmed | TCF4 promotes colorectal cancer drug resistance and stemness via regulating ZEB1/ZEB2 expression. | 6.77e-05 | 3 | 166 | 2 | 31933004 | |
| Pubmed | Microcephalin regulates BRCA2 and Rad51-associated DNA double-strand break repair. | 6.77e-05 | 3 | 166 | 2 | 19549900 | |
| Pubmed | Down-regulation of miR-144 promotes thyroid cancer cell invasion by targeting ZEB1 and ZEB2. | 6.77e-05 | 3 | 166 | 2 | 24968735 | |
| Pubmed | Interaction of huntingtin-associated protein with dynactin P150Glued. | 6.77e-05 | 3 | 166 | 2 | 9454836 | |
| Pubmed | 6.77e-05 | 3 | 166 | 2 | 17961073 | ||
| Pubmed | miR-139-5p suppresses cancer cell migration and invasion through targeting ZEB1 and ZEB2 in GBM. | 6.77e-05 | 3 | 166 | 2 | 25833697 | |
| Pubmed | 6.77e-05 | 3 | 166 | 2 | 22219182 | ||
| Pubmed | Are CYP17 genotypes a biomarker for ovarian cancer in patients with cancer history in their family? | 6.77e-05 | 3 | 166 | 2 | 16783967 | |
| Pubmed | Relation of ADRB3, GEF, ROCK2 gene polymorphisms to clinical findings in overactive bladder. | 6.77e-05 | 3 | 166 | 2 | 31802204 | |
| Pubmed | 6.77e-05 | 3 | 166 | 2 | 26022123 | ||
| Pubmed | The inner nuclear membrane protein Sun1 mediates the anchorage of Nesprin-2 to the nuclear envelope. | 6.77e-05 | 3 | 166 | 2 | 16079285 | |
| Pubmed | 6.77e-05 | 3 | 166 | 2 | 11971876 | ||
| GeneFamily | Zinc fingers|Zinc fingers PARP-type|Poly(ADP-ribose) polymerases | 2.60e-06 | 17 | 107 | 4 | 684 | |
| GeneFamily | NLR family | 1.33e-05 | 25 | 107 | 4 | 666 | |
| GeneFamily | Spectrin repeat containing nuclear envelope family | 2.07e-04 | 4 | 107 | 2 | 1252 | |
| GeneFamily | Pyrin domain containing|Pyrin and HIN domain family | 4.22e-04 | 25 | 107 | 3 | 994 | |
| GeneFamily | Olfactory receptors, family 56 | 1.22e-03 | 9 | 107 | 2 | 167 | |
| GeneFamily | WD repeat domain containing|F-box and WD repeat domain containing | 1.84e-03 | 11 | 107 | 2 | 559 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 3.46e-03 | 15 | 107 | 2 | 529 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | ROCK2 TUT4 ZEB1 DOCK9 ARFGEF1 DAPK1 MARCHF7 SPG11 BTAF1 TRRAP TRIP12 ZEB2 TDRD7 TGFBR2 DST STXBP3 BRCA2 ATAD2B SYNE2 UTP20 GOLGA4 NUP153 | 2.65e-08 | 856 | 166 | 22 | M4500 |
| Coexpression | GABRIELY_MIR21_TARGETS | RMND5A MYO9A CNTRL ARFGEF1 SPG11 TGFBR2 FANCI ATAD2B SYNE2 TACC1 PARP9 KLHL8 GOLGA4 | 4.36e-08 | 289 | 166 | 13 | M2196 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | TUT4 ZEB1 INPP4A SYNE1 DOCK9 PARP8 CNTRL ELP1 RNF213 MARCHF7 SPOCK2 FBXW2 SPG11 BTAF1 SLFN5 GIMAP7 FHIP2A TRIP12 ZEB2 ZBED5 SBNO2 TGFBR2 TACC1 PARP9 NUP153 | 8.14e-06 | 1492 | 166 | 25 | M40023 |
| Coexpression | GSE34156_UNTREATED_VS_6H_NOD2_AND_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_DN | 8.62e-06 | 160 | 166 | 8 | M8664 | |
| Coexpression | GSE21360_PRIMARY_VS_QUATERNARY_MEMORY_CD8_TCELL_DN | 4.01e-05 | 198 | 166 | 8 | M7610 | |
| Coexpression | GSE39556_UNTREATED_VS_3H_POLYIC_INJ_MOUSE_NK_CELL_UP | 4.15e-05 | 199 | 166 | 8 | M9410 | |
| Coexpression | GSE42021_CD24HI_VS_CD24INT_TCONV_THYMUS_UP | 4.30e-05 | 200 | 166 | 8 | M9591 | |
| Coexpression | GSE21670_UNTREATED_VS_TGFB_IL6_TREATED_STAT3_KO_CD4_TCELL_DN | 4.30e-05 | 200 | 166 | 8 | M7444 | |
| Coexpression | GSE17721_ALL_VS_24H_PAM3CSK4_BMDC_UP | 4.30e-05 | 200 | 166 | 8 | M4115 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | ROCK2 TUT4 ARFGEF1 DAPK1 MARCHF7 TRRAP TRIP12 TDRD7 DST ATAD2B GOLGA4 NUP153 | 4.46e-05 | 466 | 166 | 12 | M13522 |
| Coexpression | LAKE_ADULT_KIDNEY_C24_ENDOTHELIAL_CELLS_AEA_AND_DVR | 5.39e-05 | 152 | 166 | 7 | M39243 | |
| Coexpression | GSE21033_1H_VS_24H_POLYIC_STIM_DC_UP | 7.75e-05 | 161 | 166 | 7 | M7728 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | ROCK2 AFTPH TRAF3IP1 MYO9A POLA1 CNPY4 CRELD2 NCBP1 FBXW2 MACROH2A1 WDPCP RAD50 BRCA2 SYNE2 RAD54B ADAMTS20 PRR14L CDH4 GOLGA4 AGTPBP1 | 5.12e-06 | 831 | 161 | 20 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | dev gonad_e13.5_F_SupCellPrec_Sry_top-relative-expression-ranked_1000 | LRCH2 MYO5B MYO9A DOCK9 PARP8 DDIT4L RNF213 DAPK1 TEX15 LHX9 PLA2R1 CFAP54 DST GZF1 STXBP3 PDE8B NFXL1 MME KLHL8 | 1.16e-05 | 804 | 161 | 19 | gudmap_dev gonad_e13.5_F_SupCellPrec_Sry_1000 |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_top-relative-expression-ranked_1000 | MYT1L MCPH1 FBXW12 DOCK9 BACH1 DDIT4L RNF213 CLSTN2 TEX15 LHX9 SCUBE2 STXBP3 SLC12A2 PLA1A PDE8B AGL SYNE2 SCAPER | 2.31e-05 | 770 | 161 | 18 | gudmap_developingGonad_P2_ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000 | REXO5 MYO9A BACH1 DDIT4L RNF213 TEX15 ZFX LHX9 PLA2R1 SLC12A2 TESMIN BRCA2 PDE8B AFP SYNE2 SCAPER NFXL1 NUP153 | 2.56e-05 | 776 | 161 | 18 | gudmap_developingGonad_e14.5_ ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_1000 | MYT1L REXO5 DOCK9 BACH1 DDIT4L RNF213 CLSTN2 TEX15 MAP10 LHX9 PLA2R1 SCUBE2 STXBP3 SLC12A2 PDE8B SYNE2 SCAPER NUP153 | 2.65e-05 | 778 | 161 | 18 | gudmap_developingGonad_e18.5_ovary_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | TUT4 AFTPH TRAF3IP1 MYO9A CNPY4 CRELD2 FBXW2 MACROH2A1 MDM2 WDPCP BRCA2 ATAD2B SYNE2 ADAMTS20 CORIN PRR14L AGTPBP1 SMG6 | 2.74e-05 | 780 | 161 | 18 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1 |
| CoexpressionAtlas | dev gonad_e11.5_F_SupCellPrec_Sry_top-relative-expression-ranked_200 | 4.96e-05 | 171 | 161 | 8 | gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_200 | |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000 | REXO5 AFTPH MYO9A FSIP1 POLA1 TEX15 SLC30A4 SUV39H2 RAD50 TDRD7 BRCA2 GLDC FANCI DGKK RAD54B SCAPER NFXL1 HTT | 5.24e-05 | 820 | 161 | 18 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | TUT4 ZEB1 LRCH2 POLA1 CNTRL CLSTN2 ACVR1C PRC1 SUV39H2 WDPCP RAD50 CFAP54 BRCA2 GLDC ATAD2B SYNE2 NAT10 RAD54B CFAP74 CDH4 ENOX2 | 5.37e-05 | 1060 | 161 | 21 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | ROCK2 TUT4 AFTPH TRAF3IP1 MYO5B POLA1 NCBP1 MACROH2A1 RAD50 VAC14 SCUBE2 BRCA2 GLDC ATAD2B SYNE2 NAT10 UTP20 CFAP74 CDH4 GOLGA4 | 6.19e-05 | 989 | 161 | 20 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#5_top-relative-expression-ranked_1000 | 6.73e-05 | 230 | 161 | 9 | gudmap_developingGonad_e18.5_ovary_1000_k5 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | ROCK2 TUT4 ZEB1 LRCH2 MCPH1 TRAF3IP1 POLA1 CNTRL CRELD2 MARCHF7 FBXW2 MACROH2A1 BTAF1 ACVR1C SUV39H2 RAD50 BRCA2 ATAD2B SYNE2 NAT10 RAD54B UTP20 CFAP74 | 7.77e-05 | 1257 | 161 | 23 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | dev gonad_e12.5_F_SupCellPrec_Sry_top-relative-expression-ranked_500 | CPNE8 MYO5B MYO9A DDIT4L RNF213 DAPK1 TEX15 LHX9 PLA2R1 PDE8B NFXL1 KLHL8 | 7.86e-05 | 414 | 161 | 12 | gudmap_dev gonad_e12.5_F_SupCellPrec_Sry_500 |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_500 | CPNE8 MYO5B MYO9A POLA1 RNF213 DAPK1 ACVR1C ZEB2 LHX9 ADAMTS12 NFXL1 MME | 8.60e-05 | 418 | 161 | 12 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_500 |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_top-relative-expression-ranked_1000 | CPNE8 TUT4 LRCH2 MYO5B MYO9A POLA1 DDIT4L RNF213 DAPK1 TEX15 ZEB2 LHX9 ADAMTS12 PLA2R1 SYNE2 NFXL1 MME | 9.78e-05 | 783 | 161 | 17 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 1.12e-04 | 192 | 161 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_1000 | MYT1L REXO5 AFTPH MYO9A BACH1 DDIT4L RNF213 TEX15 MAP10 RYR1 LHX9 PLA2R1 SLC12A2 PDE8B AFP SYNE2 HTT | 1.17e-04 | 795 | 161 | 17 | gudmap_developingGonad_e16.5_ovary_1000 |
| CoexpressionAtlas | dev gonad_e12.5_F_SupCellPrec_Sry_top-relative-expression-ranked_1000 | CPNE8 MYO5B MYO9A DOCK9 DDIT4L RNF213 DAPK1 TEX15 LHX9 PLA2R1 DST GZF1 PDE8B NFXL1 MME KLHL8 CCDC136 | 1.32e-04 | 803 | 161 | 17 | gudmap_dev gonad_e12.5_F_SupCellPrec_Sry_1000 |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_top-relative-expression-ranked_200 | 1.63e-04 | 152 | 161 | 7 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_200 | |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_500 | MYO9A POLA1 TEX15 SUV39H2 TDRD7 BRCA2 GLDC FANCI RAD54B SCAPER NFXL1 | 1.78e-04 | 385 | 161 | 11 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_500 |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_500 | MYT1L REXO5 BACH1 DDIT4L RNF213 TEX15 LHX9 PLA2R1 PDE8B AFP SYNE2 | 1.86e-04 | 387 | 161 | 11 | gudmap_developingGonad_e16.5_ovary_500 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#2_top-relative-expression-ranked_200 | 3.41e-04 | 44 | 161 | 4 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k2_200 | |
| CoexpressionAtlas | dev gonad_e11.5_F_SupCellPrec_Sry_top-relative-expression-ranked_1000 | CPNE8 TUT4 PSAP MYO5B MYO9A DOCK9 DDIT4L ARFGEF1 RNF213 DAPK1 TEX15 TRRAP LHX9 DST NFXL1 KLHL8 | 3.49e-04 | 791 | 161 | 16 | gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_1000 |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_100 | 4.01e-04 | 82 | 161 | 5 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_100 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_500 | 4.09e-04 | 357 | 161 | 10 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_top-relative-expression-ranked_1000 | MYO9A POLA1 RNF213 NCBP1 TEX15 SUV39H2 ZBED5 RAD50 TDRD7 SLC12A2 BRCA2 GLDC NAT10 RAD54B SCAPER UTP20 | 4.52e-04 | 810 | 161 | 16 | gudmap_dev gonad_e13.5_M_GermCell_Oct_1000 |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.28e-08 | 199 | 166 | 9 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | mild-CD8+_Tem|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.56e-08 | 200 | 166 | 9 | d8aec4904c9420b8f9d7508658ba1e36c66cdfcc | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.56e-08 | 200 | 166 | 9 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated|COVID-19_Mild / Disease, condition lineage and cell class | 6.56e-08 | 200 | 166 | 9 | 2281debd86e5d92e8fe0397aec9ef670800f7471 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.44e-07 | 169 | 166 | 8 | 987ff79ad563825dd9877ea8ccb536758f8c6700 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.48e-07 | 177 | 166 | 8 | da8802a6351d3e510822f82e2fde8a4314a2216e | |
| ToppCell | COVID-19-Heart-EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 5.95e-07 | 190 | 166 | 8 | a21653bfb7bafbc273f94fa7c13bfb48cf8fd562 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.19e-07 | 191 | 166 | 8 | d9a6f61fcda4f5352488f7f55cb9b57aeacc717f | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-CytoT_GZMK+-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 6.44e-07 | 192 | 166 | 8 | ed1fb700d3e8f00495727d61e164fc0b70274fd0 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-CytoT_GZMK+|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 6.44e-07 | 192 | 166 | 8 | 6779b0294bb058e748e22b795b6a381c4add37e9 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.53e-07 | 196 | 166 | 8 | 0f3c7fd450aaa1f866b8558692534c0ea2a34e75 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.53e-07 | 196 | 166 | 8 | 4e1f8828413896ab8a4ec92a89d6789e8e37e05a | |
| ToppCell | 3'_v3-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 7.63e-07 | 135 | 166 | 7 | ae2d3a42e567b5bade304c0caa497eb725be3565 | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-CD8+_Memory_T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 7.82e-07 | 197 | 166 | 8 | 836061acd7f0d5de89b16f52ec679bdf09eac9db | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 7.82e-07 | 197 | 166 | 8 | 2e9677b4b9a7c88db16416e5f114a2031ec3bc24 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 7.82e-07 | 197 | 166 | 8 | 4c9919914079e76b1d2220b249e0d0b0d9bf4bc0 | |
| ToppCell | COVID-19_Moderate-CD8+_Tem|World / disease group, cell group and cell class | 8.12e-07 | 198 | 166 | 8 | 1d12be256af028c88e31fb535068bae16b7bd48e | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 8.44e-07 | 199 | 166 | 8 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | (04)_Interm._basal>secr.-(2)_GFP_FOXI1|(04)_Interm._basal>secr. / shred by cell type by condition | 8.44e-07 | 199 | 166 | 8 | 53ca3861f9e00dab3f3fbefb0837857ee39ab084 | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 8.44e-07 | 199 | 166 | 8 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 8.44e-07 | 199 | 166 | 8 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | Control-Control-Lymphocyte-T/NK-CD8+_Tem|Control / Disease, condition lineage and cell class | 8.76e-07 | 200 | 166 | 8 | fddb3df5b90eb97ef8ed80fac320c1a90903f012 | |
| ToppCell | severe-CD8+_Tem|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 8.76e-07 | 200 | 166 | 8 | aaa2cd326dc15dee2fd975ca133359c5826f6a75 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-CD4+_T_activated|COVID-19_Mild / Disease, condition lineage and cell class | 8.76e-07 | 200 | 166 | 8 | d9e8a0d047d4403fb7265fde7448e23a7780785c | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-T/NK-gd_T|COVID-19_Severe / Disease, condition lineage and cell class | 8.76e-07 | 200 | 166 | 8 | f72bc3f6606ae77fe1b0a972e35b3ce0727804d9 | |
| ToppCell | (08)_Brush+PNEC-(2)_GFP_FOXI1|(08)_Brush+PNEC / shred by cell type by condition | 8.85e-07 | 138 | 166 | 7 | 817e3f639604ea95adae01e8685ffaa2e0aff7a8 | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Lymphocytic-NK/T|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.48e-06 | 161 | 166 | 7 | 140b3c7077947c541cff54f6754e2df968345f4d | |
| ToppCell | facs-Pancreas-Exocrine-24m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.48e-06 | 161 | 166 | 7 | b9a17f41426bf715f30bf544a6795afaf37a3aa6 | |
| ToppCell | facs-Pancreas-Exocrine-24m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.48e-06 | 161 | 166 | 7 | f7a89c481f789f624102857be722c95fbeb47595 | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Lymphocytic-NK_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.59e-06 | 162 | 166 | 7 | 16f9fbcaa0093ffc5a2a5e32db6040e2cb519d47 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.42e-06 | 169 | 166 | 7 | 121768fc51fc3441ec725346a1bbe29e21d05971 | |
| ToppCell | Thalamus-Neuronal-Excitatory|Thalamus / BrainAtlas - Mouse McCarroll V32 | 4.47e-06 | 176 | 166 | 7 | d2bbf13d21fb7582d7e5f90cd61a4ebe1cfccd66 | |
| ToppCell | COVID-19_Mild-gd_T|COVID-19_Mild / Disease condition and Cell class | 5.78e-06 | 183 | 166 | 7 | f593a89b0aa8fffdfa403769916facfd30358521 | |
| ToppCell | LV-07._Pericyte|LV / Chamber and Cluster_Paper | 6.20e-06 | 185 | 166 | 7 | acb38eba871ec72f2a8136a33b87d33b8c85465d | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-T_lymphocytic-effector_CD4-positive,_alpha-beta_T_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.65e-06 | 187 | 166 | 7 | e61c1755531469dd3850c9740474b5ad4e0499c1 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 6.89e-06 | 188 | 166 | 7 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | T_cells-ISG-high_CD4+_T_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 6.89e-06 | 188 | 166 | 7 | 6f8946d4710f6e32c937213f99b790b098b8819c | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_T-CytoT_GZMK+-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 7.13e-06 | 189 | 166 | 7 | f1129eb122bbc051457c5545f1a267beb988b0f2 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_T-CytoT_GZMK+|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 7.13e-06 | 189 | 166 | 7 | 0b012ee301419fa9ccc387c3ff66c2344b349a97 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.13e-06 | 189 | 166 | 7 | 0e8d1be3c406d1a393e18faccfe89116a8f82bcf | |
| ToppCell | ASK452-Immune-T_cell|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq | 7.13e-06 | 189 | 166 | 7 | f5dc500f77f04a110dd4a65cf4c03068a495dbdb | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.38e-06 | 190 | 166 | 7 | b855b8b7d3439023390ca44629c1a99f5d4c6801 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD8-Tem/emra_CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 7.38e-06 | 190 | 166 | 7 | 66d29f53f129fc18771f6214316a913eeaccd55e | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.64e-06 | 191 | 166 | 7 | 696921a4f160b6b55698652488ed781e855e5e51 | |
| ToppCell | URO-Lymphocyte-T_NK-CD8_TEM|URO / Disease, Lineage and Cell Type | 7.90e-06 | 192 | 166 | 7 | 31b6d068f7adc6952c4cf625df851a10cb1b00c9 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 7.90e-06 | 192 | 166 | 7 | ab88ea7723f0fa3b39611981c043445f27425404 | |
| ToppCell | COVID-19_Severe-CD8+_T_activated|World / disease group, cell group and cell class | 8.18e-06 | 193 | 166 | 7 | ddc1db516568e03be8e82b2ca770c67756418185 | |
| ToppCell | severe-low-quality_cells|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 8.18e-06 | 193 | 166 | 7 | 9337bc93e3904c7fc7c93c328518bcd6453b1e8c | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.46e-06 | 194 | 166 | 7 | e577d9e88390b36b5a09b97fe1026089892275a3 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 8.46e-06 | 194 | 166 | 7 | 71d3c7448b1734de54187f902f65649f9283bd4c | |
| ToppCell | severe_COVID-19-CD4+_CTL|World / disease group, cell group and cell class (v2) | 8.46e-06 | 194 | 166 | 7 | bdafc1173b7b8cde8714573fbeee5394a2484a5f | |
| ToppCell | COVID-19_Severe-CD8+_Tem|World / disease group, cell group and cell class | 8.46e-06 | 194 | 166 | 7 | 60aa16e166894e3fcd82f7a54607c2c02e55b614 | |
| ToppCell | URO-Lymphocyte-T_NK|URO / Disease, Lineage and Cell Type | 8.46e-06 | 194 | 166 | 7 | 4806c07dcf1bc6d9591548382b77817568eb16b6 | |
| ToppCell | moderate-Epithelial-FOXN4+|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 8.46e-06 | 194 | 166 | 7 | dff3fb10372053951d41e0ccd41aac3ece6009bd | |
| ToppCell | COVID-19_Mild-PLT_5|COVID-19_Mild / Disease Group and Platelet Clusters | 8.74e-06 | 195 | 166 | 7 | bdf9a6ea1bd83c72a834c45f86ce3f4643a9bef3 | |
| ToppCell | T_cells-GZMK+_T_cells|T_cells / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 8.74e-06 | 195 | 166 | 7 | 003ea7ddec6c1c98d2f6470bb51ebd97450eb936 | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-gd_T|COVID-19_Severe / Disease group, lineage and cell class | 8.74e-06 | 195 | 166 | 7 | 9990440bda7fac5d00ef80444fab07459be625e1 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig-F_2|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.04e-06 | 196 | 166 | 7 | ea8eceacc5d5e1a22b77c31e7c45985dc7bb15de | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD8+_T|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.04e-06 | 196 | 166 | 7 | 093fb240e72911dfd360aa6edf8ed2d611c78a1e | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.04e-06 | 196 | 166 | 7 | 418e8e0a51c5cb60e3b903e7d2d800dc8b9f3d5c | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.04e-06 | 196 | 166 | 7 | a9157809122e6fc5783a291522f103bef30943e4 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.04e-06 | 196 | 166 | 7 | 581fc8c8d42005aacd7b401a2c9d1fc331fb4af7 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD8+_T|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.04e-06 | 196 | 166 | 7 | c06caba0c91b8ee66f42bc43ec75eb2475f07056 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 9.04e-06 | 196 | 166 | 7 | 6beaf0c2799424c59819b286fbb5c1a83d85e4d1 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.04e-06 | 196 | 166 | 7 | c35f2349dfe35baa845f790b9f31673dceac54c0 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.04e-06 | 196 | 166 | 7 | c4e7133c609bcbc48c4947ea0aa1a7d9d7251b04 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_Tem|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 9.35e-06 | 197 | 166 | 7 | 2b3a56bb1d40bc1284a5931c4e7b373660de5402 | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-CD8+_Tem|COVID-19_Severe / Disease group, lineage and cell class | 9.35e-06 | 197 | 166 | 7 | f0bac4d5c3160933ac3786cec8dadffb35d711ea | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_Tem-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 9.35e-06 | 197 | 166 | 7 | f73ece3aca28c0db5db0f12e026d42c6c36b9efb | |
| ToppCell | normal-na-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-female|normal / PBMC cell types (v2) per disease, treatment status, and sex | 9.35e-06 | 197 | 166 | 7 | b5b333e98753946793ceb45e2d85c25ef53568b4 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_Tem|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.35e-06 | 197 | 166 | 7 | e70e7d97823a762def3970d94a0e897981a6c922 | |
| ToppCell | normal-na-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell|normal / PBMC cell types (v2) per disease, treatment status, and sex | 9.35e-06 | 197 | 166 | 7 | 4cec48e202f4583c9328d4b722c49ed3471ec173 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.35e-06 | 197 | 166 | 7 | 32b770e403028862f91e4727f4a8fbb6151910e4 | |
| ToppCell | COVID-19_Moderate-CD8+_T_activated|COVID-19_Moderate / disease group, cell group and cell class | 9.35e-06 | 197 | 166 | 7 | 4711ecb157e907758a5021248ae8b043d17672c6 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_only / Treatment groups by lineage, cell group, cell type | 9.35e-06 | 197 | 166 | 7 | 1a1bee8da6e04b65935c40373eaee4d6c046d9a1 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_Tem-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.35e-06 | 197 | 166 | 7 | bce0135a96910d2bace62a3408a1a6fdac0cf0df | |
| ToppCell | severe_COVID-19-CD4+_CTL|severe_COVID-19 / disease group, cell group and cell class (v2) | 9.35e-06 | 197 | 166 | 7 | e51b7cd03b1450dc8601b4be0453b104d6a5f955 | |
| ToppCell | COVID_vent-Lymphocytic-T_cell-CD8+_Memory_T_cell|COVID_vent / Disease condition, Lineage, Cell class and subclass | 9.35e-06 | 197 | 166 | 7 | d4dfb3b561d0783cdbee4e8d27009ad81df695cb | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK|Convalescent / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.66e-06 | 198 | 166 | 7 | 24f6954aff8751885e783d68c631b04dd1980f48 | |
| ToppCell | systemic_lupus_erythematosus-treated|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 9.66e-06 | 198 | 166 | 7 | 8165ff735095c52994fb5057d89be93cc378b7da | |
| ToppCell | systemic_lupus_erythematosus-flare|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 9.66e-06 | 198 | 166 | 7 | 4c93ee921d56132d80832d8e94563f32ccf13bbc | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD4-positive_helper_T_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 9.66e-06 | 198 | 166 | 7 | c4d8d133e571ad3a7c5de93aa7befb67cb7a003d | |
| ToppCell | Sepsis-URO-Lymphocyte-T/NK-CD4+_CTL|URO / Disease, condition lineage and cell class | 9.66e-06 | 198 | 166 | 7 | c53405a8d082fbd10131a6ec88b69fdd835f2925 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.66e-06 | 198 | 166 | 7 | 4633e379893a26a746f8e29302cc54bbe04dd23f | |
| ToppCell | COVID-19_Convalescent-Lymphoid_T/NK|COVID-19_Convalescent / Disease group, lineage and cell class | 9.66e-06 | 198 | 166 | 7 | 457ba9e3f1bb6453af8cc1a6e7436af66296f8f5 | |
| ToppCell | Control-Control-Lymphocyte-T/NK-CD4+_T_activated|Control / Disease, condition lineage and cell class | 9.66e-06 | 198 | 166 | 7 | ee71543559836fd59adc0da877b2ca538cba60cb | |
| ToppCell | COVID_non-vent-Lymphocytic-ILC|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 9.98e-06 | 199 | 166 | 7 | df4f7d5be099e3e6054f3b812ccf70251664e4c0 | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-lymphocytic-T_lymphocytic-naive_thymus-derived_CD8-positive,_alpha-beta_T_cell|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 9.98e-06 | 199 | 166 | 7 | db05c16d80f5a74bfa048a5c92917d312d26f769 | |
| ToppCell | COVID_non-vent-Lymphocytic-ILC-NK_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 9.98e-06 | 199 | 166 | 7 | ed35d747f11f6ea6a5cb7061057f0a98d9e0db99 | |
| ToppCell | mild-MAIT|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.98e-06 | 199 | 166 | 7 | cbe1fb6d2c5fca7a1baf1ad20afcdf8e8e11bd84 | |
| ToppCell | COVID-19_Moderate|World / disease group, cell group and cell class | 9.98e-06 | 199 | 166 | 7 | 952fac67588ad5676f5939e3c7f8bac803c27064 | |
| ToppCell | severe-gd_T|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.98e-06 | 199 | 166 | 7 | e5a17a9f8f3be05d6abe1116607d17633df3c7ef | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.03e-05 | 200 | 166 | 7 | 72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.03e-05 | 200 | 166 | 7 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | COVID-19_Moderate-CD4+_CTL|COVID-19_Moderate / disease group, cell group and cell class | 1.03e-05 | 200 | 166 | 7 | a9c73559e2c9fda1b065bfb5ce84978995505924 | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-T/NK-CD8+_Tem|COVID-19_Severe / Disease, condition lineage and cell class | 1.03e-05 | 200 | 166 | 7 | 31859b8db7ea17e48b7b54e92f0d76aeb755e7ca | |
| ToppCell | LPS_IL1RA-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.03e-05 | 200 | 166 | 7 | 5c092b2ecc081b5d04476c56333c338cd89ab984 | |
| ToppCell | severe-gd_T|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.03e-05 | 200 | 166 | 7 | 2253d74049cc49c92e897ff4aa298d913daeb739 | |
| ToppCell | Sepsis-URO-Lymphocyte-T/NK-CD8+_Tem|URO / Disease, condition lineage and cell class | 1.03e-05 | 200 | 166 | 7 | e621b46084839700e6dd338fdafc682a07cd698d | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.03e-05 | 200 | 166 | 7 | 79e51afb57ca38aacebd0298e5e727b55c0cfff9 | |
| Disease | nephronophthisis (implicated_via_orthology) | 1.26e-05 | 9 | 159 | 3 | DOID:12712 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of breast | ZEB1 SYNE1 CYP17A1 ELP1 PRC1 MDM2 SUV39H2 ZEB2 NLRP9 NF1 BRCA2 AFP SYNE2 UTP20 LRRC7 MME AGAP2 | 7.31e-05 | 1074 | 159 | 17 | C0006142 |
| Disease | ATRIAL SEPTAL DEFECT 1 | 8.63e-05 | 3 | 159 | 2 | C1862389 | |
| Disease | Mammary Neoplasms | 1.43e-04 | 527 | 159 | 11 | C1458155 | |
| Disease | Autosomal dominant Emery-Dreifuss muscular dystrophy | 1.72e-04 | 4 | 159 | 2 | cv:CN293514 | |
| Disease | Autosomal Recessive Emery-Dreifuss Muscular Dystrophy | 2.85e-04 | 5 | 159 | 2 | C1450051 | |
| Disease | Atrial Septal Defects | 2.85e-04 | 5 | 159 | 2 | C0018817 | |
| Disease | Muckle-Wells Syndrome | 2.85e-04 | 5 | 159 | 2 | C0268390 | |
| Disease | Autosomal Dominant Emery-Dreifuss Muscular Dystrophy (disorder) | 2.85e-04 | 5 | 159 | 2 | C0410190 | |
| Disease | Drug habituation | 4.06e-04 | 115 | 159 | 5 | C0013170 | |
| Disease | Drug abuse | 4.06e-04 | 115 | 159 | 5 | C0013146 | |
| Disease | Prescription Drug Abuse | 4.06e-04 | 115 | 159 | 5 | C4316881 | |
| Disease | Substance-Related Disorders | 4.06e-04 | 115 | 159 | 5 | C0236969 | |
| Disease | Drug Use Disorders | 4.06e-04 | 115 | 159 | 5 | C0013222 | |
| Disease | Drug Dependence | 4.06e-04 | 115 | 159 | 5 | C1510472 | |
| Disease | Substance Dependence | 4.06e-04 | 115 | 159 | 5 | C0038580 | |
| Disease | Substance Use Disorders | 4.06e-04 | 115 | 159 | 5 | C0038586 | |
| Disease | Organic Mental Disorders, Substance-Induced | 4.06e-04 | 115 | 159 | 5 | C0029231 | |
| Disease | melanoma | 4.11e-04 | 248 | 159 | 7 | C0025202 | |
| Disease | Substance abuse problem | 4.23e-04 | 116 | 159 | 5 | C0740858 | |
| Disease | Emery-Dreifuss muscular dystrophy | 4.27e-04 | 6 | 159 | 2 | cv:C0410189 | |
| Disease | Liposarcoma, well differentiated | 4.27e-04 | 6 | 159 | 2 | C1370889 | |
| Disease | Muscular Dystrophy, Emery-Dreifuss | 4.27e-04 | 6 | 159 | 2 | C0410189 | |
| Disease | MEDULLOBLASTOMA | 4.27e-04 | 6 | 159 | 2 | 155255 | |
| Disease | Liposarcoma, Dedifferentiated | 4.27e-04 | 6 | 159 | 2 | C0205824 | |
| Disease | brain measurement, hippocampal volume | 4.27e-04 | 6 | 159 | 2 | EFO_0004464, EFO_0005035 | |
| Disease | Medulloblastoma | 4.27e-04 | 6 | 159 | 2 | cv:C0025149 | |
| Disease | Benign Neoplasm | 5.06e-04 | 68 | 159 | 4 | C0086692 | |
| Disease | Neoplasms | 5.06e-04 | 68 | 159 | 4 | C0027651 | |
| Disease | Breast Cancer, Familial | 5.60e-04 | 30 | 159 | 3 | C0346153 | |
| Disease | Mammary Carcinoma, Human | 5.87e-04 | 525 | 159 | 10 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 5.87e-04 | 525 | 159 | 10 | C1257931 | |
| Disease | Senior-Loken syndrome (is_implicated_in) | 5.95e-04 | 7 | 159 | 2 | DOID:0050576 (is_implicated_in) | |
| Disease | glycosyl ceramide (d18:1/20:0, d16:1/22:0) measurement | 5.95e-04 | 7 | 159 | 2 | EFO_0800551 | |
| Disease | Renal dysplasia and retinal aplasia | 5.95e-04 | 7 | 159 | 2 | cv:C0403553 | |
| Disease | X-Linked Emery-Dreifuss Muscular Dystrophy | 5.95e-04 | 7 | 159 | 2 | C0751337 | |
| Disease | Malignant Neoplasms | 6.62e-04 | 128 | 159 | 5 | C0006826 | |
| Disease | Breast Carcinoma | 7.07e-04 | 538 | 159 | 10 | C0678222 | |
| Disease | Intellectual Disability | 7.47e-04 | 447 | 159 | 9 | C3714756 | |
| Disease | Congenital adrenal hyperplasia | 1.01e-03 | 9 | 159 | 2 | C0001627 | |
| Disease | Glioma | 1.01e-03 | 9 | 159 | 2 | cv:C0017638 | |
| Disease | medulloblastoma (is_implicated_in) | 1.26e-03 | 10 | 159 | 2 | DOID:0050902 (is_implicated_in) | |
| Disease | Marfan syndrome (implicated_via_orthology) | 1.26e-03 | 10 | 159 | 2 | DOID:14323 (implicated_via_orthology) | |
| Disease | Fanconi anemia (is_implicated_in) | 1.26e-03 | 10 | 159 | 2 | DOID:13636 (is_implicated_in) | |
| Disease | Diarrhea | 1.54e-03 | 11 | 159 | 2 | C0011991 | |
| Disease | complement C1q tumor necrosis factor-related protein 1 measurement | 1.84e-03 | 12 | 159 | 2 | EFO_0801493 | |
| Disease | Renal dysplasia and retinal aplasia (disorder) | 1.84e-03 | 12 | 159 | 2 | C0403553 | |
| Disease | Emery-Dreifuss muscular dystrophy (implicated_via_orthology) | 1.84e-03 | 12 | 159 | 2 | DOID:11726 (implicated_via_orthology) | |
| Disease | granulins measurement | 1.84e-03 | 12 | 159 | 2 | EFO_0008141 | |
| Disease | motor neuron disease (implicated_via_orthology) | 1.84e-03 | 12 | 159 | 2 | DOID:231 (implicated_via_orthology) | |
| Disease | rheumatic heart disease (biomarker_via_orthology) | 1.84e-03 | 12 | 159 | 2 | DOID:0050827 (biomarker_via_orthology) | |
| Disease | Male sterility | 2.22e-03 | 48 | 159 | 3 | C0917731 | |
| Disease | Male infertility | 2.22e-03 | 48 | 159 | 3 | C0021364 | |
| Disease | Subfertility, Male | 2.22e-03 | 48 | 159 | 3 | C0848676 | |
| Disease | Fanconi anemia | 2.52e-03 | 14 | 159 | 2 | cv:C0015625 | |
| Disease | Majewski Syndrome | 2.52e-03 | 14 | 159 | 2 | C0024507 | |
| Disease | Hereditary Breast and Ovarian Cancer Syndrome | 2.52e-03 | 14 | 159 | 2 | C0677776 | |
| Disease | forehead morphology measurement | 2.89e-03 | 15 | 159 | 2 | EFO_0007844 | |
| Disease | myocardial infarction | 2.98e-03 | 350 | 159 | 7 | EFO_0000612 | |
| Disease | Neuralgia, Supraorbital | 3.29e-03 | 16 | 159 | 2 | C0038870 | |
| Disease | Neuralgia | 3.29e-03 | 16 | 159 | 2 | C0027796 | |
| Disease | Neuralgia, Atypical | 3.29e-03 | 16 | 159 | 2 | C0234247 | |
| Disease | Neuralgia, Stump | 3.29e-03 | 16 | 159 | 2 | C0234249 | |
| Disease | Neuralgia, Iliohypogastric Nerve | 3.29e-03 | 16 | 159 | 2 | C0423712 | |
| Disease | Neuralgia, Perineal | 3.29e-03 | 16 | 159 | 2 | C0423711 | |
| Disease | Paroxysmal Nerve Pain | 3.29e-03 | 16 | 159 | 2 | C0751373 | |
| Disease | Nerve Pain | 3.29e-03 | 16 | 159 | 2 | C0751372 | |
| Disease | Neuralgia, Ilioinguinal | 3.29e-03 | 16 | 159 | 2 | C0751371 | |
| Disease | Neuralgia, Vidian | 3.29e-03 | 16 | 159 | 2 | C0042656 | |
| Disease | Amyotrophic lateral sclerosis | 3.72e-03 | 17 | 159 | 2 | cv:C0002736 | |
| Disease | Moyamoya Disease | 3.72e-03 | 17 | 159 | 2 | C0026654 | |
| Disease | migraine disorder, systolic blood pressure | 4.17e-03 | 18 | 159 | 2 | EFO_0006335, MONDO_0005277 | |
| Disease | Bone marrow hypocellularity | 4.17e-03 | 18 | 159 | 2 | C1855710 | |
| Disease | Bardet-Biedl syndrome | 4.17e-03 | 18 | 159 | 2 | cv:C0752166 | |
| Disease | oral squamous cell carcinoma (is_marker_for) | 4.81e-03 | 63 | 159 | 3 | DOID:0050866 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LVAEVVEKCSSKTCS | 101 | O75410 | |
| KVKLCSQSLELCLSY | 541 | Q7Z4L5 | |
| TKCSISKLELSAAEQ | 1056 | Q13075 | |
| KECLLKLCDTELAIT | 491 | Q8N944 | |
| CTCLLKESAKAQLSS | 986 | Q86US8 | |
| IKCCLLLDSVCSTIE | 1206 | P53355 | |
| LILSKENVDEVCKCV | 96 | O14867 | |
| NVEKKTDCCILSALL | 2011 | Q96N23 | |
| SKCEVCKLLSTELQA | 36 | Q8N129 | |
| RALQSCVECLSKEKE | 1776 | Q7Z7A1 | |
| VKCRKENSALKECLT | 51 | Q7Z7K0 | |
| DLETSCSDIRQFCKK | 786 | Q14203 | |
| QCKTEEKLDLLTSKC | 351 | Q6ULP2 | |
| LQTLLCDTDSKCKDT | 71 | Q86UK0 | |
| DKTCNCTLDIFKTTI | 1521 | Q9Y6D6 | |
| CNKSITAKEALICPT | 56 | Q92974 | |
| TVCDLIQSKCLSKEN | 251 | P28799 | |
| EVAEKLKCLDLSETC | 111 | Q9H116 | |
| LKCLDLSETCFQLKK | 116 | Q9H116 | |
| CEELLEKTVKNCLAL | 286 | O75367 | |
| NILSVLCEKSCNQKL | 331 | P28335 | |
| SKNILVKKCETCAIA | 326 | Q8NER5 | |
| ASLQCCESSKVKLRT | 911 | Q99490 | |
| NVCKKLDRIVCDSSV | 116 | Q96D03 | |
| SNKICLDLNVSCISK | 706 | Q96PN6 | |
| SQKVISCLQACKEGL | 531 | Q9H4D0 | |
| LDKNECVCKLSSSVK | 716 | A2RUS2 | |
| KDCSLPLTVLTCAKA | 556 | Q9UPW5 | |
| DLLCTKDKLSASFCQ | 1536 | P58397 | |
| LITREDICSSKEKCN | 356 | P59510 | |
| CLLFNSIKEKECSST | 596 | Q9Y620 | |
| KVISTACSLEDKQCL | 171 | O95825 | |
| KNIDQCSEIVKCSVS | 1291 | Q92878 | |
| KECLEKCIEQNITSI | 411 | Q8IXQ6 | |
| LADKTRQLVTVCDCK | 451 | Q96PE3 | |
| NKQSSIKCVEDVSLC | 621 | Q9UPP5 | |
| IIKNCICSNLSVSKL | 176 | Q8NGH8 | |
| ICSNLSVSKLSCDDI | 181 | Q8NGH8 | |
| CLVCDKTLLGKESLQ | 666 | Q8N1W1 | |
| NITCESSKKLCIFDS | 361 | Q4KMQ2 | |
| LSGEECKKQLINTLC | 151 | Q9NVI1 | |
| LSRDAIICEVCKVKS | 351 | Q5KSL6 | |
| TNDINCCLSIKSKLQ | 96 | Q8N3A8 | |
| IGKCCLNKLSSDDAV | 111 | Q8TDR0 | |
| KRLICEVSLCKINSK | 171 | Q14667 | |
| GSLNISKQCKDICEL | 881 | Q9P2G4 | |
| SKQCKDICELVINKL | 886 | Q9P2G4 | |
| TLNADKKTCSALDRC | 296 | O15232 | |
| KLAADNKSCLAIDLC | 246 | O95460 | |
| NDIKSDVCISSLVLK | 256 | Q8NEM0 | |
| LESLICKVGEKSACS | 31 | Q09161 | |
| ITTADVNEKNLLSCC | 751 | Q6ZNB6 | |
| NICSVCKLGTDKETL | 16 | Q9NYK6 | |
| IKCCKCLTIIEASVN | 111 | Q96NW7 | |
| KTFLKEVDCCTTLQL | 286 | P59045 | |
| CKTDIKCRLAKSTLT | 341 | P43220 | |
| QLDICCKKTEALLEA | 1216 | Q13439 | |
| CKDLIDPCTSEKVSL | 1706 | Q03001 | |
| CDSGDKCSSEQKILL | 1296 | Q9ULI0 | |
| LENLKEKESCASRLC | 496 | Q16206 | |
| LVVCTKCDAISVLEK | 241 | Q9Y6G9 | |
| KSIICSVSPKQELCA | 116 | Q6X9E4 | |
| EKCLSVACLDKNELS | 371 | Q00613 | |
| LCDVTLKVGSKLISC | 66 | Q9P2G9 | |
| LKCCECKLALESELT | 96 | Q9NQ69 | |
| IETCVECSAKNLKNI | 141 | Q8IXI2 | |
| SLKKLCCTTDNNKQI | 376 | O95263 | |
| VALENISCKIKSGCE | 181 | Q8TAT6 | |
| ICKSSDCIKSAARLI | 56 | P08473 | |
| CITRITNTEKCLKEL | 76 | Q9UN81 | |
| CCNSKTKSVVLQLAD | 561 | O95163 | |
| SDGCCDLTKLLQEKS | 911 | Q9NX02 | |
| CFLQIKCDTKDDSIL | 1536 | Q9UKK3 | |
| EISKSLCCRNLAVEK | 116 | Q6ZMK1 | |
| IVCSDLNKTECDKQT | 96 | Q9BZM2 | |
| CDVEISAKELIRCKS | 691 | P09884 | |
| LASCKKCLVIDDQLN | 191 | Q9H0A0 | |
| LVDCCKTLDQAKAVL | 251 | Q9H0A0 | |
| ICTNVSVSKLSCDDI | 181 | P0C7T3 | |
| EITDFLCRDKKCIAS | 1686 | Q5VYJ5 | |
| LKSKAISCCRNVTED | 336 | O95876 | |
| KDESSVTCKLACTAV | 816 | P42858 | |
| EILKCCNSKLSSIRT | 1481 | Q9BZ29 | |
| SLETSDICKCSIGKL | 1951 | P51587 | |
| NSKIIKNLCSSLCVD | 916 | O14981 | |
| KLEKIICQEISTLCD | 141 | P05093 | |
| SNTSIIKVKVCPCDD | 701 | P55283 | |
| ESRSKISLLCTKQDC | 776 | Q9Y5Q5 | |
| NCVKALVEKCSRITS | 366 | Q8NEE6 | |
| KPDCIITCDSKNLTI | 6 | A8MUU1 | |
| SSLEAVTTCELCKEK | 596 | Q9H992 | |
| VTTCELCKEKLELNL | 601 | Q9H992 | |
| VLESTSCLSEEQLKC | 396 | Q8NA03 | |
| VLKCDITDLQIICSL | 746 | Q14831 | |
| LCSKEEKCVKNLCRT | 191 | Q6UWM5 | |
| IIALCEEKLQLTSSC | 171 | Q76NI1 | |
| AKCLTQSTCLCELLT | 296 | Q5W0V3 | |
| NCKCLKTLSVSEDRS | 311 | Q9UKT8 | |
| VDECSLAEKTCVRKN | 291 | Q6UXH1 | |
| KEVTASCDLSCIVKR | 566 | Q9NQ36 | |
| KKQCSLCNVLISSEV | 791 | Q9BY12 | |
| LQCSATVLKEQLKLC | 21 | P21817 | |
| SCQLKKSLETAGDCK | 121 | Q8TAU0 | |
| CSTKKCSLSLDKELI | 611 | Q9C0B2 | |
| KKCGTIILTAEELNC | 141 | Q86YQ8 | |
| KCKLCARENSIEILS | 66 | Q9NWV4 | |
| QQDTLSNKITECCKL | 291 | P02771 | |
| SNKITECCKLTTLER | 296 | P02771 | |
| LDACKKLGVSQERLC | 716 | Q5VUJ6 | |
| LKIKKSCEENVCRSL | 1126 | Q5THK1 | |
| LNCIALCEVITSKDL | 561 | Q2NL67 | |
| SSQELEDASCCSLKK | 191 | Q9Y4I5 | |
| LDLHTKVTKTNCCES | 301 | O75691 | |
| LKDLKTLESQNLFCC | 606 | Q08AM6 | |
| QCSECTKSTEQINLK | 51 | P0CI25 | |
| TLSLVLTQCCKRIKD | 56 | Q9H871 | |
| IITKLCDKISNKDIC | 366 | Q8IYR2 | |
| TNLKKCSTSPLLEAC | 691 | P02788 | |
| QELLACQENCKKTLT | 856 | Q8NF91 | |
| ILSQRIEKAKCLCDE | 3086 | Q8WXH0 | |
| FSCQLQCKSEDLKLL | 771 | B5MCY1 | |
| EECCTLAKKLEQISQ | 601 | Q86SQ7 | |
| KESLDTTCKEISRCI | 71 | Q8NHV1 | |
| DCKKTIVNDSRESCV | 361 | Q00987 | |
| IKSISVCQKELNTLC | 66 | O43663 | |
| KLLNSSCSLEKTLQC | 11 | Q8N7X8 | |
| KSSNILVKNDLTCCL | 381 | P37173 | |
| CLDVEKDCSITKFLN | 956 | Q9Y2G9 | |
| KNVLDCCISLLTESS | 186 | P49221 | |
| NATCLKAICDKSLEV | 631 | Q8NHU6 | |
| LNCSDCSIKVTKVDE | 796 | Q8NHU6 | |
| LLDEFTTKLLASCCK | 36 | O00186 | |
| CIQAGKSVLTLENCK | 51 | Q13018 | |
| KCANKCDTLLSRLTE | 531 | Q96JN2 | |
| LEKAKVSLNDCLACS | 61 | Q9H6Q4 | |
| EKLDVAIQCDLISKC | 606 | Q86WS4 | |
| QELENLKCSILACSA | 526 | Q9H9A5 | |
| CEDIASVLACNSKLK | 731 | Q7RTR0 | |
| NETIKNSKLEVSCCA | 346 | Q96JI7 | |
| KLCILCQILKDTSIA | 1641 | Q96JI7 | |
| LQASVTVSCDLKIAC | 441 | Q53H76 | |
| TVCLKLHEAICSSTK | 846 | Q63HN8 | |
| EVRNCLTNTAKCKIL | 3361 | Q63HN8 | |
| KNDSCTIKENVCIID | 1046 | Q8N2E2 | |
| VLCALSQKSSLKDCS | 376 | Q9ULJ3 | |
| CCSDSESKTNIVKVI | 1436 | Q8IVF5 | |
| CQTIKCLSNKEVLEQ | 451 | Q96IC2 | |
| DTLQELCRKEKLTCK | 21 | Q9H5I1 | |
| QCSECTKSTEQINLK | 51 | P0CI26 | |
| IVTELTNCTSAACKL | 556 | P55011 | |
| LTESAAIACVKLCKA | 316 | P21359 | |
| CSLLDCDLKQSQQKI | 761 | O75116 | |
| CSNALKDLSLSIICK | 686 | Q4G0T1 | |
| GCSLLSVDEKELKCQ | 1106 | Q86WI1 | |
| DCELCLVQNKADSTK | 856 | P49790 | |
| LVQNKADSTKCLACE | 861 | P49790 | |
| CSKLPKSLSEECQEV | 346 | P07602 | |
| CDLCDKIFQKSSSLL | 906 | P37275 | |
| IKQKEIDSEDICSIC | 136 | Q8NEG5 | |
| KKLCESDVCQSSSLT | 256 | Q16670 | |
| QCVLCKKILSNSSLA | 131 | Q49AG3 | |
| SQLSLKVDSCDNCSK | 86 | O14863 | |
| KVDSCDNCSKQREIL | 91 | O14863 | |
| KVCCALLISESQKLA | 76 | Q9UL40 | |
| KCDICLLTFSDTKEV | 606 | P17010 | |
| EEIKSTCSLKACFSL | 71 | P0CG31 | |
| QSCREKELLKTEQCS | 1376 | Q9BXT5 | |
| KELLKTEQCSSGNCL | 1381 | Q9BXT5 | |
| CDLCDKTFQKSSSLL | 1001 | O60315 | |
| LTHQDKKSVESTCLC | 611 | Q14669 | |
| LKKELSQCNCIDLSK | 826 | Q5TAX3 | |
| RCELIKESEVKALCA | 16 | P60510 | |
| KAIETALDCLKSANT | 941 | Q9Y4A5 | |
| CQVIGCEKEKIDLTS | 236 | Q08AF3 | |
| EDLIQKSLGTCQDCK | 51 | Q8TEY7 | |
| SSVCKLEQQACLSSK | 156 | Q92563 | |
| KELSECKECTEIVNT | 216 | Q8TAF7 | |
| QKCCLFTESLKLNLE | 196 | Q9Y473 | |
| KDEKAIECNLCQSSI | 851 | Q9P2D8 | |
| DTLKIQCGCSVKEVL | 436 | P23378 | |
| NEITKEKEQCCVSLA | 1071 | P35573 | |
| KKTQEDAEAICSLCT | 1751 | Q9ULV0 | |
| VCSSESITCKPQLKD | 1396 | B2RTY4 | |
| QCKESKKDLITLSGC | 871 | Q9UL68 |